P175: Fatigue and its severity depends on demographic and clinical factors in the Polish population of patients with inflammatory bowel disease - results of a cross-sectional studyECCO '18 Vienna
2018
P176: Improving quality of care through patient´s eyes: Results from IQCARO project focus groupsECCO '18 Vienna
2018
P177: Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic reviewECCO '18 Vienna
2018
P178: Sleep fragmentation measured by wearable device is an indicator of clinical disease activity in inflammatory bowel diseaseECCO '18 Vienna
2018
P179: Visceral fat hypertrophy does not have an impact on the activity and severity of Crohn’s diseaseECCO '18 Vienna
2018
P180: Role of hydrosonography of small bowel in the detection of inflammatory bowel diseaseECCO '18 Vienna
2018
P181: A retrospective analysis of the clinical application of the multigene analysis test DiBiCol® to differentiate between ulcerative colitis and Crohn’s disease and Non-IBDECCO '18 Vienna
2018
P182: Intestinal diffuse neuroendocrine system and proliferation indicators in prediction of non-specific ulcerative colitis occurrence and courseECCO '18 Vienna
2018
P184: 3D endoanal ultrasound: diagnosis and follow-up of anal fistulas in Crohn’s diseaseECCO '18 Vienna
2018
P185: Natural history of Crohn’s disease postoperative recurrence in a referral centre in the era of biologics and therapeutic intensification based on early endoscopic findingsECCO '18 Vienna
2018
P186: Outcomes of maintenance ustekinumab therapy for Crohn’s disease based on inflammatory burden: A post-hoc analysis of the UNITI trialsECCO '18 Vienna
2018
P187: Correlation between the Lemann Index and the Inflammatory Bowel Disease-Disability Index in Crohn’s diseaseECCO '18 Vienna
2018
P188: Do you see what I see? An assessment of recognition and description of endoscopic inflammation by gastroenterology trainees and staff physiciansECCO '18 Vienna
2018
P189: Diffusion-weighted magnetic resonance enterography for prediction of response to tumour necrosis factor inhibitors in stricturing Crohn’s diseaseECCO '18 Vienna
2018
P190: Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with Quiescent Small Bowel Crohn’s diseaseECCO '18 Vienna
2018